Old Web
English
Sign In
Acemap
>
authorDetail
>
J Mordenti
J Mordenti
Antibiotics
Microbiology
Biology
Ceftizoxime
Cephalosporin
5
Papers
155
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study.
2002
Alimentary Pharmacology & Therapeutics
William J. Tremaine
A. Brzezinski
Jeffry A. Katz
D. C. Wolf
T. J. Fleming
J Mordenti
L. C. Strenkoski‐Nix
M.C. Kurth
Show All
Source
Cite
Save
Citations (79)
Comment: Pharmaceutics of acetaminophen, vancomycin, and antipyrine on the Hanford miniature swine.
1990
Drug Metabolism and Disposition
J Mordenti
Show All
Source
Cite
Save
Citations (0)
Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.
1987
Antimicrobial Agents and Chemotherapy
John F. Flaherty
Steven L. Barriere
J Mordenti
John G. Gambertoglio
Show All
Source
Cite
Save
Citations (10)
Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
1985
Antimicrobial Agents and Chemotherapy
S. L. Barriere
D C Ozasa
J Mordenti
Show All
Source
Cite
Save
Citations (13)
Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals.
1985
Antimicrobial Agents and Chemotherapy
J Mordenti
Show All
Source
Cite
Save
Citations (53)
1